Transforming Growth Factor β as a Predictor of Liver and Lung Fibrosis after Autologous Bone Marrow Transplantation for Advanced Breast Cancer

New England Journal of Medicine

Volumn 328, Issue 22, 1993, Pages 1592-1598

  Anscher, Mitchell S ^a   Peters, William P ^a   Reisenbichler, Herbert ^a   Petros, William P ^a   Jirtle, Randy L ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ANIMAL CELL; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BREAST CARCINOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISSEMINATED CANCER; FEMALE; HUMAN; INTERSTITIAL PNEUMONIA; LIVER FIBROSIS; LIVER VENOOCCLUSIVE DISEASE; LUNG FIBROSIS; MINK; MULTIMODALITY CANCER THERAPY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

ADENOCARCINOMA; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW TRANSPLANTATION; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HEPATIC VENO-OCCLUSIVE DISEASE; HUMAN; LIVER CIRRHOSIS; MIDDLE AGE; PULMONARY FIBROSIS; SUPPORT, U.S. GOV'T, P.H.S.; TRANSFORMING GROWTH FACTOR BETA;

EID: 0027193827     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199306033282203     Document Type: Article

References (51)

1. McDonald GB, Shulman HM, Wolford JL, Spencer GD Liver disease after human marrow transplantation. Semin Liver Dis 1987; 7:210-229
2. McDonald GB, Sharma P, Matthews DE, Shulman HM, Thomas ED Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology 1984; 4:116-122
3. McDonald GB, Shulman HM, Sullivan KM, Spencer GD Intestinal and hepatic complications of human bone marrow transplantation. Gastroenterology 1986; 90:770-784
4. Brodsy R, Topolsky D, Crilley P, Bulova S, Brodsky I Frequency of veno-occlusive disease of the liver in bone marrow transplantation with a modified busulfan/cyclophosphamide preparative regimen. Am J Clin Oncol 1990; 13:221-225
5. Ganem G, Saint Marc Girardin MF, Kuentz M, Venocclusive disease of the liver after allogeneic bone marrow transplantation in man. Int J Radiat Oncol Biol Phys 1988; 14:879-884
6. Ozkaynak MF, Weinberg K, Kohn D, Sender L, Parkman R, Lenarsky C Hepatic veno-occlusive disease post-bone marrow transplantation in children conditioned with busulfan and cyclophosphamide: incidence, risk factors, and clinical outcome. Bone Marrow Transplant 1991; 7:467-474
7. Jones RJ, Lee KSK, Beschorner WE, Venoocclusive disease of the liver following bone marrow transplantation. Transplantation 1987; 44:778-783
8. Ettinger NA, Trulock EP Pulmonary considerations of organ transplantation. Am Rev Respir Dis 1991; 144:213-223
9. Noble PW The pulmonary complications of bone marrow transplantation in adults. West J Med 1989; 150:443-449
10. Hackman RC, Madtes DK, Petersen FB, Clark JG Pulmonary venoocclusive disease following bone marrow transplantation. Transplantation 1989; 47:989-992
11. Shulman HM, Gown AM, Nugent DJ Hepatic venoocclusive disease after bone marrow transplantation: immunohistochemical identification of the material within occluded central venules. Am J Pathol 1987; 127:549-558
12. Amento EP, Beck LS. TGF-β and wound healing. In: Bock GR, Marsh J, eds. Clinical applications of TGFβ. West Sussex, England: John Wiley, 1991:115-29.
13. Mustoe TA, Pierce GF, Thomason A, Gramates P, Sporn MB, Deuel TF Accelerated healing of incisional wounds in rats induced by transforming growth factor-β. Science 1987; 237:1333-1336
14. Lynch SE, Colvin RB, Antoniades HN Growth factors in wound healing: single and synergistic effects on partial thickness porcine skin wounds. J Clin Invest 1989; 84:640-646
15. Kelley J, Kovacs EJ, Nicholson K, Fabisiak JP Transforming growth factor-β production by lung macrophages and fibroblasts. Chest 1991; 99: Suppl: 85S-86S
16. Hoyt DG, Lazo JS Alterations in pulmonary mRNA encoding procollagens, fibronectin and transforming growth factor-β precede bleomycin-induced pulmonary fibrosis in mice. J Pharmacol Exp Ther 1988; 246:765-771
17. Khalil N, Bereznay O, Sporn M, Greenberg AH Macrophage production of transforming growth factor β and fibroblast collagen synthesis in chronic pulmonary inflammation. J Exp Med 1989; 170:727-737
18. Raghow R, Irish P, Kang AH Coordinate regulation of transforming growth factor β gene expression and cell proliferation in hamster lungs undergoing bleomycin-induced pulmonary fibrosis. J Clin Invest 1989; 84:1836-1842
19. Phan SH, Gharaee-Kermani M, Wolber F, Ryan US Stimulation of rat endothelial cell transforming growth factor-β production by bleomycin. J Clin Invest 1991; 87:148-154
20. Hoyt DG, Lazo JS Early increases in pulmonary mRNA encoding procollagens transforming growth factor-β in mice sensitive to cyclophosphamide-induced pulmonary fibrosis. J Pharmacol Exp Ther 1989; 249:38-43
21. Anscher MS, Crocker IR, Jirtle RL Transforming growth factor-β1 expression in irradiated liver. Radiat Res 1990; 122:77-85
22. Czaja MJ, Weiner FR, Flanders KC, In vitro and in vivo association of transforming growth factor-β1 with hepatic fibrosis. J Cell Biol 1989; 108:2477-2482
23. Nakatsukasa H, Nagy P, Evarts RP, Hsia C-C, Marsden E, Thorgeirsson SS Cellular distribution of transforming growth factor-β1 and procollagen types I, III, and IV transcripts in carbon tetrachloride-induced rat liver fibrosis. J Clin Invest 1990; 85:1833-1843
24. Milani S, Herbst H, Schuppan D, Stein H, Surrenti C Transforming growth factors β1 and β2 are differentially expressed in fibrotic liver disease. Am J Pathol 1991; 139:1221-1229
25. Armendariz-Borunda J, Seyer JM, Kang AH, Raghow R Regulation of TGFβ gene expression in rat liver intoxicated with carbon tetrachloride. FASEB J 1990; 4:215-221
26. Yamauchi K, Martinet Y, Basset P, Fells GA, Crystal RG High levels of transforming growth factor-β are present in the epithelial lining fluid of the normal human lower respiratory tract. Am Rev Respir Dis 1988; 137:1360-1363
27. Raghu G, Masta S, Meyers D, Narayanan AS Collagen synthesis by normal and fibrotic human lung fibroblasts and the effect of transforming growth factor-β. Am Rev Respir Dis 1989; 140:95-100
28. Castilla A, Prieto J, Fausto N Transforming growth factors β1 and α in chronic liver disease – effects of interferon alfa therapy. N Engl J Med 1991; 324:933-940
29. Limper AH, Broekelmann TJ, Colby TV, Malizia G, McDonald JA Analysis of local mRNA expression for extracellular matrix proteins and growth factors using in situ hybridization in fibroproliferative lung disorders. Chest 1991; 99: Suppl: 55S-56S
30. Broekelmann TJ, Limper AH, Colby TV, McDonald JA Transforming growth factor β1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sci U S A 1991; 88:6642-6646
31. Harrison NK, Argent AC, McAnulty RJ, Black CM, Corrin B, Laurent GJ Collagen synthesis and degradation by systemic sclerosis lung fibroblasts: responses to transforming growth factor-β. Chest 1991; 99: Suppl: 71S-72S
32. Varga J, Haustein UF, Creech RH, Dwyer JP, Jimenez SA Exaggerated radiation-induced fibrosis in patients with systemic sclerosis. JAMA 1991; 265:3292-3295
33. Kahaleh MB, LeRoy EC The immune basis for human fibrotic diseases, especially scleroderma (systemic sclerosis). Clin Aspects Autoimmun 1989; 3:19-28
34. Border WA, Okuda S, Languino LR, Sporn MB, Ruoslahti E Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1. Nature 1990; 346:371-374
35. Lie TS, Preissinger H, Bach M, The protective effect of cyclosporine against cirrhotic alteration of the liver. Surgery 1991; 110:847-853
36. Peters WP, Shpall EJ, Jones RB, High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer. J Clin Oncol 1988; 6:1368-1376
37. Proper JA, Bjornson CL, Moses HL Mouse embryos contain polypeptide growth factor(s) capable of inducing a reversible neoplastic phenotype in nontransformed cells in culture. J Cell Physiol 1982; 110:169-174
38. Roberts AB, Lamb LC, Newton DL, Sporn MB, DeLarco JE, Todaro GJ Transforming growth factors: isolation of polypeptides from virally and chemically transformed cells by acid/ethanol extraction. Proc Natl Acad Sci U S A 1980; 77:3494-3498
39. Danielpour D, Dart LL, Flanders KC, Roberts AB, Sporn MB Immunodetection and quantitation of the two forms of transforming growth factor-β (TGF-β1 and TGF-β2) secreted by cells in culture. J Cell Physiol 1989; 138:79-86
40. Freund JE. Modern elementary statistics. 3rd ed. Englewood Cliffs, N.J.: Prentice-Hall, 1967.
41. Bearman SI, Appelbaum FR, Buckner CD, Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol 1988; 6:1562-1568
42. 1 to prevent veno-occlusive disease of the liver after bone marrow transplantation. Nouv Rev Fr Hematol 1990; 32:1-3
43. Piedbois P, Ganem G, Cordonnier C, Interstitial pneumonitis and venocclusive disease of the liver after bone marrow transplantation. Radiother Oncol 1990; 18: Suppl 1: 125-127
44. Scrobohaci ML, Drouet L, Monem-Mansi A, Liver veno-occlusive disease after bone marrow transplantation changes in coagulation parameters and endothelial markers. Thromb Res 1991; 63:509-519
45. Weiner RS, Horowitz MM, Gale RP, Risk factors for interstitial pneumonia following bone marrow transplantation for severe aplastic anaemia. Br J Haematol 1989; 71:535-543
46. Wingard JR, Mellits ED, Jones RJ, Association of hepatic veno-occlusive disease with interstitial pneumonitis in bone marrow transplant recipients. Bone Marrow Transplant 1989; 4:685-689
47. Lucas C, Bald LN, Fendly BM, The autocrine production of transforming growth factor-β1 during lymphocyte activation: a study with a monoclonal antibody-based ELISA. J Immunol 1990; 145:1415-1422
48. Massague J The transforming growth factor-β family. Annu Rev Cell Biol 1990; 6:597-641
49. Kovacina KS, Steele-Perkins G, Purchio AF, Interactions of recombinant and platelet transforming growth factor-β1 precursor with the insulin-like growth factor II/mannose 6-phosphate receptor. Biochem Biophys Res Commun 1989; 160:393-403
50. Jirtle RL, Carr BI, Scott CD Modulation of insulin-like growth factor-II/ mannose 6-phosphate receptors and transforming growth factor-β1 during liver regeneration. J Biol Chem 1991; 266:22444-22450 [Erratum, J Biol Chem 1991;266:24860.]
51. Jirtle RL, Meyer SA Liver tumor promotion: effect of phenobarbital on EGF and protein kinase C signal transduction and transforming growth factor-β1 expression. Dig Dis Sci 1991; 36:659-668